Prescription

Citius Prescription drugs, Inc. Submits Biologics License Software to the U.S. Food and Drug Administration for Denileukin Diftitox for the Remedy of Clients with Persistent or Recurrent Cutaneous T-Cell Lymphoma

CRANFORD, N.J., Sept. 28, 2022 /PRNewswire/ -- Citius Prescribed drugs, Inc. ("Citius" or the "Enterprise") (Nasdaq: CTXR), a late-phase biopharmaceutical...

Aurinia Prescription drugs Inc.’s (NASDAQ:AUPH) market place cap dropped US$71m very last week person traders who maintain 57% have been strike as have been institutions

Glenmark Prescription drugs Inc., United states proceeds to broaden its More than-The-Counter (OTC) Portfolio with the acquisition of accredited ANDAs from Wockhardt Restricted

MUMBAI, India and MAHWAH, N.J., June 28, 2022 /PRNewswire/ -- Glenmark Prescribed drugs Ltd., an innovation-pushed, global pharmaceutical enterprise, announced...